Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
From ProQR Therapeutics N.V.
Via GlobeNewswire
Tickers PRQR
News headline image
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Tickers NAUT
News headline image
Allegro MicroSystems to Announce Third Quarter Fiscal Year 2026 Financial Results
From Allegro MicroSystems, Inc.
Via GlobeNewswire
Tickers ALGM
News headline image
Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care
From Rocket Doctor AI Inc.
Via GlobeNewswire
Tickers AIRDF CSE:AIDR
News headline image
Vickery Energy Acquires Appalachia Gas Assets from Tribune Resources
From Vickery Energy Partners, LLC
Via GlobeNewswire
News headline image
Coralogix Announces U.S. Department of Education Sponsorship for FedRAMP® Authorization
From Coralogix Inc.
Via GlobeNewswire
News headline image
Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders
From RENEXXION IRELAND
Via GlobeNewswire
News headline image
R1 Launches Phare Audit, the AI-Native Solution to Capture Full Reimbursement, Reduce Revenue Leakage and Improve Quality
From R1 RCM Holdco Inc.
Via GlobeNewswire
News headline image
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
From BONE BIOLOGICS CORPORATION
Via GlobeNewswire
Tickers BBLG BBLGW
News headline image
RAMSEY SOLUTIONS RELAUNCHES EVERYDOLLAR TO HELP USERS ACHIEVE $20 BILLION IN FINANCIAL TRANSFORMATION PER YEAR BY 2030
From Ramsey Solutions
Via GlobeNewswire
News headline image
SiTime to Present at the Needham Growth Conference on January 13, 2026
From SiTime
Via GlobeNewswire
Tickers SITM
News headline image
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
From Alps Group Inc
Via GlobeNewswire
Tickers ALPS
News headline image
Meltwater Achieves SOC 2 Type II Certification, Reinforcing Commitment to Data Security and Trust
From Meltwater
Via GlobeNewswire
News headline image
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
From Recludix Pharma, Inc.
Via GlobeNewswire
News headline image
LPL Financial Welcomes Rand, Williams & Associates, LLC
From LPL Financial Holdings, Inc.
Via GlobeNewswire
Tickers LPLA
News headline image
Collegium Provides 2026 Financial Guidance and Business Update
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)
From AskBio Inc. (AskBio)
Via GlobeNewswire
News headline image
Blue Star Families Welcomes New Advisory Board Members to Advance Military Family Initiatives
From Blue Star Families
Via GlobeNewswire
News headline image
Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
From Alveus Therapeutics Inc
Via GlobeNewswire
News headline image
ElevateBio Achieves Sixth Consecutive Year of Revenue Growth Driven by Expansion of its Genetic Medicine Technology and Manufacturing Business
From ElevateBio
Via GlobeNewswire
News headline image
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Tickers ENOV
News headline image
Atsena Completes Dosing in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis and Announces Plans for Initiation of Pivotal Part C Cohort
From Atsena Therapeutics
Via GlobeNewswire
News headline image
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11
From Acrivon Therapeutics, Inc
Via GlobeNewswire
Tickers ACRV
News headline image
Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Vera Therapeutics
Via GlobeNewswire
Tickers VERA
News headline image
Public Affairs, Reputation and Issues Management Expert Joshua Baca Joins FTI Consulting
From FTI Consulting, Inc.
Via GlobeNewswire
Tickers FCN
News headline image
Exodus Movement, Inc. December 2025 Treasury Update and Monthly Metrics
From Exodus
Via GlobeNewswire
News headline image
Aurora Spine Announces Issuance of Two U.S. Patents
From Aurora Spine Corporation
Via GlobeNewswire
Tickers ASAPF TSX-V:ASG
News headline image
Howard Hughes Holdings Inc. Announces Dates and Times for 2025 Fourth Quarter Earnings Release and Conference Call
From Howard Hughes Holdings Inc.
Via GlobeNewswire
Tickers HHH
News headline image
SchoolAI Research Challenges Fears About AI in the Classroom with Evidence From 23,000 Teacher-Created Lessons
From SchoolAI
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.